About The Medical Condition MDL-17,043
Find the definition of the medical term MDL-17,043. MDL-17,043 defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
MDL-17,043
| MDL-17,043 Medical Condition |
|---|
What's The Definition Of The Medical Condition MDL-17,043?
1,3-Dihydro-4-methyl-5-(4-(methylthio)benzoyl)-2H-imidazol-2-one. A selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption. It is used in patients with congestive heart failure.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Basic Polypeptide, Cardiotoxin-Like ‐ Most abundant proteins in cobra (Naja of the Elapids) venom;…
- Gramoderm ‐ A group of antibiotics (ANTIBIOTICS, PEPTIDE) from Bacillus brevis.…
- Zona ‐ An acute infectious, usually self-limited, disease believed to…
- Beta Disease, Broad ‐ A rather uncommon form of familial hyperlipemia characterized…
- Dentistry, Occupational ‐ The branch of dentistry concerned with maintaining oral health…
- Prairie Dogs ‐ A family of the order Rodentia which contains 49 genera. Some…
- Erythromycin Propionate Monododecyl Sulfate ‐ A macrolide antibiotic, produced by Streptomyces erythreus. It…
- Antigenic Variability ‐ Change in the surface antigen of a microorganism. There are two…
- Replication, Autonomous ‐ The process by which a DNA molecule is…
- Folding, Globular Protein ‐ A rapid biochemical reaction involved in the formation of proteins.…